Profile
Full Name
Context Therapeutics Inc.Ticker Symbol
CNTXExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
October 20, 2021Indexes
Not includedEmployees
12Key Details
Price
$0.84(-1.40%)
Market cap
$75.62M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$0.46(+69.33% YoY)
PE ratio
-
Next earnings date
May 30, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Context Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 9, 25 D. Boral Capital
BuyMar 21, 25 HC Wainwright & Co.
BuyMar 21, 25 D. Boral Capital
BuyJan 15, 25 D. Boral Capital
BuyJan 8, 25 JMP Securities
Market OutperformNov 25, 24 D. Boral Capital
BuySep 23, 24 HC Wainwright & Co.
BuySep 16, 24 HC Wainwright & Co.
BuyJul 10, 24 HC Wainwright & Co.
BuyMay 16, 24 Piper Sandler
OverweightInstitutional Ownership
- What is the ticker symbol for Context Therapeutics?
- Does Context Therapeutics pay dividends?
- What sector is Context Therapeutics in?
- What industry is Context Therapeutics in?
- What country is Context Therapeutics based in?
- When did Context Therapeutics go public?
- Is Context Therapeutics in the S&P 500?
- Is Context Therapeutics in the NASDAQ 100?
- Is Context Therapeutics in the Dow Jones?
- When was Context Therapeutics's last earnings report?
- When does Context Therapeutics report earnings?
- Should I buy Context Therapeutics stock now?
What is the ticker symbol for Context Therapeutics?
The ticker symbol for Context Therapeutics is NASDAQ:CNTX
Does Context Therapeutics pay dividends?
No, Context Therapeutics does not pay dividends
What sector is Context Therapeutics in?
Context Therapeutics is in the Healthcare sector
What industry is Context Therapeutics in?
Context Therapeutics is in the Biotechnology industry
What country is Context Therapeutics based in?
Context Therapeutics is headquartered in United States
When did Context Therapeutics go public?
Context Therapeutics's initial public offering (IPO) was on October 20, 2021
Is Context Therapeutics in the S&P 500?
No, Context Therapeutics is not included in the S&P 500 index
Is Context Therapeutics in the NASDAQ 100?
No, Context Therapeutics is not included in the NASDAQ 100 index
Is Context Therapeutics in the Dow Jones?
No, Context Therapeutics is not included in the Dow Jones index
When was Context Therapeutics's last earnings report?
Context Therapeutics's most recent earnings report was on Mar 20, 2025
When does Context Therapeutics report earnings?
The next expected earnings date for Context Therapeutics is May 30, 2025
Should I buy Context Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions